Seeking Alpha

Antigenics Inc. (AGEN)

()

News & PR
Market Currents

Buzz
Twitter: AGEN

Business Intelligence
Transcripts
Events
Key Developments

Analysis - Latest Articles by most recent | most commented

Mentor Capital Cancer Vaccine Investing Update

Dec 23 • Mike Havrilla • 1 Comment
Still Believe in Antigenics

Nov 24 • VFC's Stock House • 8 Comments
Four Biotech Stocks to Play the Sector Pullback

Nov 3 • VFC's Stock House • 35 Comments
BioMed Momentum Index: A Pause that Refreshes or More Pain to Come?

Oct 29 • Mike Havrilla • 1 Comment
Biotech Sector Pullback: Good Time to Buy at a Discount

Oct 28 • VFC's Stock House • 5 Comments
Investing in Stocks of Various Price Levels: What Really Constitutes a Penny Stock?

Oct 28 • VFC's Stock House • 4 Comments
ImmunoCellular's Promising Brain Cancer Vaccine

Oct 28 • Mike Havrilla • 2 Comments
Antigenics Should Rise on the Promise of Cancer Immunotherapy Treatments

Oct 27 • VFC's Stock House • 8 Comments
Tough Decisions for Antigenics

Oct 22 • EP Vantage • 3 Comments
Pick Up Antigenics at a Bargain Price

Oct 22 • VFC's Stock House • 22 Comments
BioMed News: Antigenics, Shire, King Pharma, Delcath Systems

Oct 21 • Mike Havrilla • 29 Comments
Dendreon: New Board Members Appointed, Things Have Never Looked Brighter

Oct 12 • VFC's Stock House • 5 Comments
Stock Watch: CPST, CVM, AGEN

Oct 6 • VFC's Stock House • 3 Comments
Have to Like the Risk / Reward in Antigenics Stock

Sep 27 • VFC's Stock House • 9 Comments
Still a Lot of Potential in Dendreon and the Cancer Immunotherapy Market

Sep 25 • VFC's Stock House • 7 Comments
Antigenics, Cel-Sci Could Both Become Billion Dollar Companies

Sep 23 • VFC's Stock House • 19 Comments
Antigenics: Why So Many Shorts?

Sep 15 • VFC's Stock House • 6 Comments
Cell Therapeutics Looks Good, Antigenics Looks Better

Sep 8 • VFC's Stock House • 4 Comments
Antigenics' Current Price Is Irresistible

Sep 6 • VFC's Stock House • 3 Comments
Antigenics May Finally Be Back on the Uptick

Sep 2 • VFC's Stock House • 1 Comment
Cell Therapeutics Could Be a Real Winner, But Not Right Now

Aug 27 • VFC's Stock House • 12 Comments
BioDelivery Sciences, Antigenics, Cel-Sci All Look Like Winners

Aug 25 • VFC's Stock House • 6 Comments
Stock Watch: VNDA, TTNP.PK, SIRI, CSUH.OB, AGEN

Aug 24 • VFC's Stock House • 42 Comments
As Market Drops, It's Time to Buy

Aug 18 • VFC's Stock House • 12 Comments
Stock Watch: TTNP, VNDA, DNDN, AGEN, ONTY

Aug 17 • VFC's Stock House • 3 Comments
Six Stock Briefs

Aug 14 • VFC's Stock House • 1 Comment
Feuerstein Comments on Antigenics: Weak at Best

Aug 6 • VFC's Stock House • 15 Comments
Investors Show Confidence in Cancer Immunotherapy Stocks

Aug 4 • VFC's Stock House • 2 Comments
Antigenics: The Big Boys Are Buying

Aug 3 • VFC's Stock House • 4 Comments
Understanding Antigenics' Private Placement

Aug 2 • VFC's Stock House • 4 Comments
Extreme FDA Trades: 30 Stocks Under 5 Bucks

Aug 2 • Mike Havrilla • 22 Comments
Biotech Volatility: Antigenics, BioDelivery Sciences

Jul 29 • VFC's Stock House • 7 Comments
Small Biopharma Ponderings

Jul 27 • VFC's Stock House • Comment!
3 Biotech Stocks on the Move

Jul 23 • VFC's Stock House • 3 Comments
Biodelivery Sciences, Antigenics: Biotech Stocks That Require Patience

Jul 12 • VFC's Stock House • 6 Comments
Extreme FDA Trades: Another 18 Stocks Under 5 Bucks

Jul 5 • Mike Havrilla • 2 Comments
5 More Stock Briefs

Jul 1 • VFC's Stock House • 10 Comments
Antigenics: Why I Couldn't Resist Buying on the Dip

Jun 24 • VFC's Stock House • 3 Comments
7 More Stock Briefs

Jun 18 • VFC's Stock House • 1 Comment
Healthcare Stocks: Favorable Reaction to Treasury Markets

Jun 12 • M. E. Garza • 1 Comment
Hemispherx and Antigenics' Vaccine Adjuvants: Indispensable for Vaccines

Jun 12 • Prohost Biotech • 5 Comments

Antigenics Inc. (AGEN)

Analysis - Latest Articles by most recent | most commented

The Seeking Alpha 100

Fastest Climbers

Top Commenters

Top Instabloggers

Top StockTalkers